Champions Oncology Inc (NASDAQ: CSBR) stock enjoyed a major increase of 18.8% on 1/3/25. The shares closed at $9.74. Moreover, unusually high trading volume at 184% of normal accompanied the advance. The stock has been strong relative to the market over the last nine months and has risen 23.8% during the last week.
Current PriceTarget Research Rating
Champions Oncology is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment